Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
1.680
-0.020 (-1.18%)
At close: Dec 5, 2025, 4:00 PM EST
1.690
+0.010 (0.60%)
After-hours: Dec 5, 2025, 7:56 PM EST
Cyclerion Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 2.86 | 2 | - | 0.3 | 3.94 | 2.3 | Upgrade
|
| Revenue Growth (YoY) | 1371.65% | - | - | -92.47% | 71.69% | -49.06% | Upgrade
|
| Cost of Revenue | 0.21 | - | - | 5.58 | 37.64 | 56.41 | Upgrade
|
| Gross Profit | 2.65 | 2 | - | -5.28 | -33.69 | -54.12 | Upgrade
|
| Selling, General & Admin | 5.99 | 5.34 | 8.33 | 13.26 | 20.62 | 28.82 | Upgrade
|
| Research & Development | 0.29 | 0.29 | 1.32 | - | - | - | Upgrade
|
| Operating Expenses | 6.28 | 5.63 | 9.65 | 13.26 | 20.62 | 28.82 | Upgrade
|
| Operating Income | -3.63 | -3.63 | -9.65 | -18.54 | -54.31 | -82.93 | Upgrade
|
| Interest Expense | - | - | - | - | -0.02 | - | Upgrade
|
| Interest & Investment Income | 0.12 | 0.21 | 0.36 | 0.29 | - | 0.3 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.36 | - | - | - | 0.29 | Upgrade
|
| EBT Excluding Unusual Items | -3.52 | -3.06 | -9.29 | -18.25 | -54.33 | -82.35 | Upgrade
|
| Asset Writedown | - | - | -3.3 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 2.68 | 4.54 | Upgrade
|
| Pretax Income | -2.2 | -3.06 | -12.59 | -18.25 | -51.65 | -77.8 | Upgrade
|
| Earnings From Continuing Operations | -2.2 | -3.06 | -12.59 | -18.25 | -51.65 | -77.8 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 7.33 | -25.83 | - | - | Upgrade
|
| Net Income | -2.2 | -3.06 | -5.26 | -44.08 | -51.65 | -77.8 | Upgrade
|
| Net Income to Common | -2.2 | -3.06 | -5.26 | -44.08 | -51.65 | -77.8 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 14.72% | 7.70% | 7.59% | 11.03% | 28.75% | 11.04% | Upgrade
|
| EPS (Basic) | -0.77 | -1.21 | -2.25 | -20.28 | -26.39 | -51.18 | Upgrade
|
| EPS (Diluted) | -0.77 | -1.21 | -2.25 | -20.28 | -26.39 | -51.18 | Upgrade
|
| Free Cash Flow | -1.38 | -4.33 | -21.25 | -40.61 | -36.52 | -74.01 | Upgrade
|
| Free Cash Flow Per Share | -0.48 | -1.72 | -9.09 | -18.69 | -18.66 | -48.69 | Upgrade
|
| Gross Margin | 92.64% | 100.00% | - | - | - | - | Upgrade
|
| Operating Margin | -127.25% | -181.40% | - | -6242.42% | -1377.83% | -3612.11% | Upgrade
|
| Profit Margin | -77.02% | -152.85% | - | -14841.08% | -1310.17% | -3388.59% | Upgrade
|
| Free Cash Flow Margin | -48.16% | -216.65% | - | -13673.74% | -926.53% | -3223.61% | Upgrade
|
| EBITDA | - | - | -9.58 | -18.48 | -53.84 | -80.64 | Upgrade
|
| D&A For EBITDA | - | - | 0.07 | 0.07 | 0.47 | 2.3 | Upgrade
|
| EBIT | -3.63 | -3.63 | -9.65 | -18.54 | -54.31 | -82.93 | Upgrade
|
| EBIT Margin | -127.25% | -181.40% | - | - | - | - | Upgrade
|
| Revenue as Reported | 2.86 | 2 | - | 0.3 | 3.94 | 2.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.